MikeTrendsTrends right now

search

clinical researchers

Trends

  1. 1
    Scientists Identify New Potential Target for Hypertension Treatment▼Scientists Discover a New Potential Treatment Target for High Blood Pressure✉newsHealthMedicine19 h ago

    Researchers have identified a new potential treatment target for high blood pressure, a condition affecting over a billion people worldwide and a leading risk factor for heart disease and stroke. The discovery could open the door to new drug development beyond existing blood pressure medications. Details of the findings and their clinical significance remain limited.

  2. 2
    Clinical Trial Data Exposed in Academic Database Breaches●Clinical trial data including genetic and medical history information has been exposed in academic research database breMmastodonScienceBiology332 min ago

    Breaches of academic research databases have exposed clinical trial data, including genetic and medical history information, affecting thousands of trial participants. Privacy advocates are urging people to exercise their rights under HIPAA, which allows patients to obtain their medical records and a list of everyone those records were shared with, and to request corrections where needed.

  3. 3
    Highlights from World Cancer Congress 2026, Part Two▼Highlights from World Cancer Congress 2026 – Part 2✉newsWorldUS Politics1 h ago

    Part two of a roundup of highlights from the World Cancer Congress 2026 has been published, covering key presentations, research findings and discussions from the global oncology meeting. The continued coverage suggests sustained interest in developments presented at the congress among cancer researchers and clinicians worldwide.

  4. 4
    Epigenetic Editing Moves Closer to Clinical Use▼Epigenetic Editing Steps Closer to the Clinic as Bioengineering Tools Mature✉newsScienceBiology32 min ago

    Epigenetic editing, which alters gene activity without changing DNA sequence, is reportedly approaching clinical application as bioengineering tools mature. Advances in gene-regulation technologies are making it feasible to target epigenetic marks precisely, opening the door to therapies for diseases rooted in gene expression rather than genetic mutations. The development signals a shift from laboratory research toward translational medicine, with researchers watching how safety and delivery challenges are addressed.

  5. 5
    Blood test distinguishes bacterial from viral infections in newborns▼Blood test shows whether newborns with fever have bacterial or viral infection✉newsHealthMedicine19 h ago

    Researchers have developed a blood test that can show whether a newborn with a fever has a bacterial or a viral infection. The advance could help doctors decide quickly whether infants need antibiotics, reducing unnecessary treatment and speeding up care for babies with serious bacterial illness. Medical outlets are reporting on the test's potential to improve diagnosis in newborns, a group in whom infections are hard to distinguish and can become dangerous fast.

  6. 6
    Longevity boom is running ahead of the science●The longevity boom is getting ahead of the science https://www. aljazeera.com/opinions/2026/9/ 27/the-longevity-boom-is-MmastodonWorld110 h ago

    An Al Jazeera opinion piece argues that the booming longevity industry — anti-ageing treatments, supplements and clinics — is outpacing the scientific evidence behind it. The author warns that commercial hype around extending lifespan is promoting products and promises before rigorous research has validated them, urging caution from consumers and stronger oversight of a rapidly growing wellness market.

  7. 7
    AI Clinical Monitoring Tool Reported to Cut Trial Costs by Millions▼AI Clinical Monitoring Tool Saves Millions in Trial Costs✉newsTechnologyAI23 min ago

    An AI-powered clinical monitoring tool is reported to have saved millions of dollars in clinical trial costs, according to coverage in The Scientist. The tool is said to streamline monitoring of trial sites, reducing manual oversight work and associated expenses. The report highlights growing interest in applying artificial intelligence to make drug development faster and cheaper, though detailed figures and trial specifics were not provided.

  8. 8
    Psychedelic Drugs Market Set to Grow Through 2035●Psychedelic Drugs Market Forecast to 2035: Demand Accelerates on Mental Health Crisis and Regulatory Breakthroughs✉newsHealthMental Health1 d ago

    A new market forecast projects the psychedelic drugs market to expand through 2035, driven by rising demand for mental health treatments and regulatory breakthroughs in approving psychedelic-based therapies. Industry analysts say growing acceptance of substances like psilocybin and MDMA for conditions such as depression and PTSD is attracting investment, though clinical and legal hurdles remain ahead of widespread adoption.

  9. 9
    Scientists explore growing replacement teeth to regrow lost ones▼Lost a tooth? Science may one day grow it back✉newsScienceBiology12 h ago

    Research into tooth regeneration is drawing attention, with reports suggesting science may one day allow people to regrow lost teeth instead of relying on implants or dentures. The work builds on studies of stem cells and the biological mechanisms that form teeth during development, raising hopes for future clinical treatments.

  10. 10
    Could age explain conflicting psychedelic study results?▼Could age help explain why psychedelic studies reach different conclusions?✉newsHealthMental Health22 min ago

    Researchers are examining whether participants' age may help explain why psychedelic studies reach different conclusions. Older adults may respond differently to psychedelic therapies than younger participants, which could account for variability across trials. The question matters as psychedelics move closer to regulated clinical use for depression and other mental health conditions.

  11. 11
    Eric Deutsch on the Fast-Growing Science Linking Radiation Oncology and Immunology▼Eric Deutsch: The Science Is Expanding Fast at the Interface of Radiation Oncology, Immunology, and Technology✉newsScience1 h ago

    Radiation oncology expert Eric Deutsch says science is expanding rapidly at the intersection of radiation therapy, immunology, and technology, as combined approaches such as radiotherapy paired with immunotherapy gain ground in cancer treatment. His remarks highlight how technological advances and immune-based research are reshaping how clinicians think about radiation's role beyond tumour destruction.